FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164858635> ?p ?o ?g. }

• W3164858635 endingPage "4125" @default.
• W3164858635 startingPage "4117" @default.
• W3164858635 abstract "To evaluate outcomes for men with biochemically recurrent prostate cancer who were selected for transponder-guided salvage radiotherapy (SRT) to the prostate bed alone by 68Ga-labelled prostate-specific membrane antigen positron emission tomography (68Ga-PSMA-PET).This is a single-arm, prospective study of men with a prostate-specific antigen (PSA) level rising to 0.1-2.5 ng/mL following radical prostatectomy. Patients were staged with 68Ga-PSMA-PET and those with a negative finding, or a positive finding localised to the prostate bed, continued to SRT only to the prostate bed alone with real-time target-tracking using electromagnetic transponders. The primary endpoint was freedom from biochemical relapse (FFBR, PSA > 0.2 ng/mL from the post-radiotherapy nadir). Secondary endpoints were time to biochemical relapse, toxicity and patient-reported quality of life (QoL).Ninety-two patients (median PSA of 0.18 ng/ml, IQR 0.12-0.36), were screened with 68Ga-PSMA-PET and metastatic disease was found in 20 (21.7%) patients. Sixty-nine of 72 non-metastatic patients elected to proceed with SRT. At the interim (3-year) analysis, 32 (46.4%) patients (95% CI 34.3-58.8%) were FFBR. The median time to biochemical relapse was 16.1 months. The rate of FFBR was 82.4% for ISUP grade-group 2 patients. Rates of grade 2 or higher gastrointestinal and genitourinary toxicity were 0% and 15.2%, respectively. General health and disease-specific QoL remained stable.Pre-SRT 68Ga-PSMA-PET scans detect metastatic disease in a proportion of patients at low PSA levels but fail to improve FFBR. Transponder-guided SRT to the prostate bed alone is associated with a favourable toxicity profile and preserved QoL.ACTRN12615001183572, 03/11/2015, retrospectively registered." @default.
• W3164858635 created "2021-06-07" @default.
• W3164858635 creator A5009933856 @default.
• W3164858635 creator A5022521164 @default.
• W3164858635 creator A5024212622 @default.
• W3164858635 creator A5026240088 @default.
• W3164858635 creator A5027273589 @default.
• W3164858635 creator A5030152675 @default.
• W3164858635 creator A5030625757 @default.
• W3164858635 creator A5032399894 @default.
• W3164858635 creator A5034099540 @default.
• W3164858635 creator A5042081531 @default.
• W3164858635 creator A5044519122 @default.
• W3164858635 creator A5047565056 @default.
• W3164858635 creator A5053818278 @default.
• W3164858635 creator A5064536913 @default.
• W3164858635 creator A5065579020 @default.
• W3164858635 creator A5076622084 @default.
• W3164858635 creator A5080627838 @default.
• W3164858635 creator A5081221251 @default.
• W3164858635 creator A5084807051 @default.
• W3164858635 creator A5086680226 @default.
• W3164858635 date "2021-06-02" @default.
• W3164858635 modified "2023-09-30" @default.
• W3164858635 title "68Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial" @default.
• W3164858635 cites W191229692 @default.
• W3164858635 cites W1987809679 @default.
• W3164858635 cites W2007912355 @default.
• W3164858635 cites W2017622807 @default.
• W3164858635 cites W2104870101 @default.
• W3164858635 cites W2132142385 @default.
• W3164858635 cites W2156399381 @default.
• W3164858635 cites W2299477037 @default.
• W3164858635 cites W2346061096 @default.
• W3164858635 cites W2510755861 @default.
• W3164858635 cites W2511755939 @default.
• W3164858635 cites W2585109238 @default.
• W3164858635 cites W2734786464 @default.
• W3164858635 cites W2767318939 @default.
• W3164858635 cites W2808736367 @default.
• W3164858635 cites W2900003817 @default.
• W3164858635 cites W2900752862 @default.
• W3164858635 cites W2913023403 @default.
• W3164858635 cites W2920101943 @default.
• W3164858635 cites W2921646286 @default.
• W3164858635 cites W2939242994 @default.
• W3164858635 cites W2942532764 @default.
• W3164858635 cites W2945553324 @default.
• W3164858635 cites W2973483310 @default.
• W3164858635 cites W2977371710 @default.
• W3164858635 cites W2981066984 @default.
• W3164858635 cites W2989413482 @default.
• W3164858635 cites W3012827461 @default.
• W3164858635 cites W3092506186 @default.
• W3164858635 cites W4239462704 @default.
• W3164858635 doi "https://doi.org/10.1007/s00345-021-03735-0" @default.
• W3164858635 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8571130" @default.
• W3164858635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34076753" @default.
• W3164858635 hasPublicationYear "2021" @default.
• W3164858635 type Work @default.
• W3164858635 sameAs 3164858635 @default.
• W3164858635 citedByCount "1" @default.
• W3164858635 countsByYear W31648586352023 @default.
• W3164858635 crossrefType "journal-article" @default.
• W3164858635 hasAuthorship W3164858635A5009933856 @default.
• W3164858635 hasAuthorship W3164858635A5022521164 @default.
• W3164858635 hasAuthorship W3164858635A5024212622 @default.
• W3164858635 hasAuthorship W3164858635A5026240088 @default.
• W3164858635 hasAuthorship W3164858635A5027273589 @default.
• W3164858635 hasAuthorship W3164858635A5030152675 @default.
• W3164858635 hasAuthorship W3164858635A5030625757 @default.
• W3164858635 hasAuthorship W3164858635A5032399894 @default.
• W3164858635 hasAuthorship W3164858635A5034099540 @default.
• W3164858635 hasAuthorship W3164858635A5042081531 @default.
• W3164858635 hasAuthorship W3164858635A5044519122 @default.
• W3164858635 hasAuthorship W3164858635A5047565056 @default.
• W3164858635 hasAuthorship W3164858635A5053818278 @default.
• W3164858635 hasAuthorship W3164858635A5064536913 @default.
• W3164858635 hasAuthorship W3164858635A5065579020 @default.
• W3164858635 hasAuthorship W3164858635A5076622084 @default.
• W3164858635 hasAuthorship W3164858635A5080627838 @default.
• W3164858635 hasAuthorship W3164858635A5081221251 @default.
• W3164858635 hasAuthorship W3164858635A5084807051 @default.
• W3164858635 hasAuthorship W3164858635A5086680226 @default.
• W3164858635 hasBestOaLocation W31648586351 @default.
• W3164858635 hasConcept C121608353 @default.
• W3164858635 hasConcept C126322002 @default.
• W3164858635 hasConcept C126894567 @default.
• W3164858635 hasConcept C143998085 @default.
• W3164858635 hasConcept C203092338 @default.
• W3164858635 hasConcept C20417620 @default.
• W3164858635 hasConcept C2776235491 @default.
• W3164858635 hasConcept C2776694085 @default.
• W3164858635 hasConcept C2777008409 @default.
• W3164858635 hasConcept C2779466945 @default.
• W3164858635 hasConcept C2780192828 @default.
• W3164858635 hasConcept C2780775027 @default.
• W3164858635 hasConcept C2781406297 @default.

• next